PS-027 - FXR agonists with sustained systemic rather than transient intestinal exposure are more efficacious in a diet-induced obese non-alcoholic steatohepatitis mouse model

Autor: Wagner, B., Brigham, D., Lee, K.-J., Ortiz, A., Lu, N., Qian, J., Douglas, K., Nagasawa, J., Govek, S., Feigh, M., Veidal, S., Vrang, N., Song, K., Smith, N.
Zdroj: In Journal of Hepatology 2017 66(1) Supplement:S18-S19
Databáze: ScienceDirect
Externí odkaz: